NATCOPHARM.BONATCOPHARM.BOBSE
Loading
Year-over-year research & development expense growth
Percentile
P21
Within normal range
vs 3Y Ago
-0.8x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -14.12% |
| 2024 | 35.76% |
| 2023 | -46.97% |
| 2022 | 18.04% |
| 2021 | -7.65% |
| 2020 | -17.75% |
| 2019 | 46.68% |
| 2018 | 37.53% |
| 2017 | 68.48% |
| 2016 | 16.18% |